Report overview
Live attenuated vaccines are vaccines made from killed pathogens.
This report contains market size and forecasts of Live Attenuated Vaccines for Pets in global, including the following market information:
Global Live Attenuated Vaccines for Pets Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Live Attenuated Vaccines for Pets Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Live Attenuated Vaccines for Pets companies in 2022 (%)
The global Live Attenuated Vaccines for Pets market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Virus Attenuated Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Live Attenuated Vaccines for Pets include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Live Attenuated Vaccines for Pets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Attenuated Vaccines for Pets Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, by Type, 2022 (%)
Virus Attenuated Vaccine
Bacterial Attenuated Vaccine
Global Live Attenuated Vaccines for Pets Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Dird
Others
Global Live Attenuated Vaccines for Pets Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Attenuated Vaccines for Pets revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Live Attenuated Vaccines for Pets revenues share in global market, 2022 (%)
Key companies Live Attenuated Vaccines for Pets sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Live Attenuated Vaccines for Pets sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
